Carlsmed, Inc. (CARL)

Carlsmed Statistics

Total Valuation

Carlsmed has a market cap or net worth of $387.33 million. The enterprise value is $294.95 million.

Market Cap	387.33M
Enterprise Value	294.95M

Important Dates

The last earnings date was Wednesday, February 25, 2026, after market close.

Earnings Date	Feb 25, 2026
Ex-Dividend Date	n/a

Share Statistics

Carlsmed has 26.58 million shares outstanding. The number of shares has increased by 249.74% in one year.

Current Share Class	26.58M
Shares Outstanding	26.58M
Shares Change (YoY)	+249.74%
Shares Change (QoQ)	+26.16%
Owned by Insiders (%)	11.73%
Owned by Institutions (%)	17.61%
Float	9.50M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.67
Forward PS	5.43
PB Ratio	3.92
P/TBV Ratio	3.92
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	5.84
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.87, with a Debt / Equity ratio of 0.18.

Current Ratio	8.87
Quick Ratio	8.48
Debt / Equity	0.18
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-21.38

Financial Efficiency

Return on equity (ROE) is -47.62% and return on invested capital (ROIC) is -24.03%.

Return on Equity (ROE)	-47.62%
Return on Assets (ROA)	-21.01%
Return on Invested Capital (ROIC)	-24.03%
Return on Capital Employed (ROCE)	-26.39%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	$505,110
Profits Per Employee	-$302,180
Employee Count	100
Asset Turnover	0.56
Inventory Turnover	8.78

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	12.69
200-Day Moving Average	n/a
Relative Strength Index (RSI)	65.85
Average Volume (20 Days)	138,432

Short Selling Information

The latest short interest is 623,507, so 2.35% of the outstanding shares have been sold short.

Short Interest	623,507
Short Previous Month	610,796
Short % of Shares Out	2.35%
Short % of Float	6.56%
Short Ratio (days to cover)	2.61

Income Statement

In the last 12 months, Carlsmed had revenue of $50.51 million and -$30.22 million in losses. Loss per share was -$2.12.

Revenue	50.51M
Gross Profit	38.04M
Operating Income	-30.57M
Pretax Income	-29.63M
Net Income	-30.22M
EBITDA	-30.29M
EBIT	-30.57M
Loss Per Share	-$2.12

Balance Sheet

The company has $109.79 million in cash and $17.41 million in debt, with a net cash position of $92.38 million or $3.47 per share.

Cash & Cash Equivalents	109.79M
Total Debt	17.41M
Net Cash	92.38M
Net Cash Per Share	$3.47
Equity (Book Value)	98.87M
Book Value Per Share	3.72
Working Capital	112.39M

Cash Flow

In the last 12 months, operating cash flow was -$28.98 million and capital expenditures -$642,000, giving a free cash flow of -$29.62 million.

Operating Cash Flow	-28.98M
Capital Expenditures	-642,000
Free Cash Flow	-29.62M
FCF Per Share	-$1.11

Margins

Gross margin is 75.31%, with operating and profit margins of -60.53% and -58.67%.

Gross Margin	75.31%
Operating Margin	-60.53%
Pretax Margin	-58.67%
Profit Margin	-58.67%
EBITDA Margin	-59.97%
EBIT Margin	-60.53%
FCF Margin	n/a

Dividends & Yields

Carlsmed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-249.74%
Shareholder Yield	-249.74%
Earnings Yield	-7.80%
FCF Yield	-7.65%

Analyst Forecast

The average price target for Carlsmed is $20.25, which is 38.98% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$20.25
Price Target Difference	38.98%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3